Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients
Clinical trial NCT02990338 · COMPLETED
Trial details
- NCT number
- NCT02990338
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2018-11-22
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.